bioMérieux S.A.
BMXMF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.86 | 12.67 | 1.28 | 0.70 |
| FCF Yield | 1.14% | 2.27% | 0.44% | 0.94% |
| EV / EBITDA | 30.57 | 24.35 | 27.32 | 24.62 |
| Quality | ||||
| ROIC | 3.48% | 4.47% | 4.85% | 4.26% |
| Gross Margin | 57.09% | 55.46% | 55.88% | 50.99% |
| Cash Conversion Ratio | 1.97 | 2.24 | 0.92 | 1.52 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.18% | 9.73% | 11.59% | 12.54% |
| Free Cash Flow Growth | -39.99% | 485.50% | -57.17% | 4,662.50% |
| Safety | ||||
| Net Debt / EBITDA | 0.26 | 0.08 | 0.72 | 0.35 |
| Interest Coverage | 0.00 | 22.49 | 90.09 | 99.59 |
| Efficiency | ||||
| Inventory Turnover | 0.90 | 0.89 | 0.83 | 1.03 |
| Cash Conversion Cycle | 115.79 | 111.53 | 118.39 | 96.46 |